Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The category 'Non-specific skin barrier and inflammatory mediators' refers to a broad physiological complex rather than a single molecular target. The skin barrier, primarily the stratum corneum, serves as the body's first line of defense against environmental pathogens and prevents excessive transepidermal water loss, often maintained by proteins like filaggrin and lipids like ceramides (StatPearls, 2023). Free radicals, or reactive oxygen species (ROS), are highly reactive molecules generated by UV exposure or metabolic processes that can cause oxidative damage to cellular DNA and lipids (NIH, 2022). Inflammatory mediators, including cytokines such as IL-1 and TNF-alpha, are signaling molecules released in response to barrier disruption or oxidative stress to coordinate an immune response (PubMed, 2021). Therapeutic interventions targeting this complex are multi-factorial, utilizing emollients to restore barrier integrity, antioxidants to quench free radicals, and anti-inflammatory agents to mitigate tissue damage. Because this grouping encompasses a wide array of lipids, proteins, and small molecules, it is considered a non-specific therapeutic focus rather than a canonical drug target.
Physical occlusion of the stratum corneum, replenishment of intercellular lipids, neutralization of reactive oxygen species through electron donation, and inhibition of cyclooxygenase or cytokine signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific skin barrier and inflammatory mediators.